Exhaled breath particles as a diagnostic tool for bronchiolitis obliterans syndrome in lung transplant recipients: a longitudinal study
Open Access
- 23 May 2025
- journal article
- transplantation
- Published by Frontiers Media SA in Frontiers in Transplantation
- Vol. 4, 1516728
Abstract
Background: Long-term survival after lung transplantation is significantly shorter compared with other solid organ transplantations. Chronic lung allograft dysfunction (CLAD), including bronchiolitis obliterans syndrome (BOS), remains the major barrier to survival. CLAD is diagnosed according to ISHLT's guidelines: a 20% drop in FEV1 using spirometry for CLAD grade 1. Given the difficulties of confounders using spirometry, other methods for precise diagnostics are being explored. Exhaled breath particles (EBP) measured as particle flow rate (PFR) from the airways have been explored as a potential method to diagnose lung injury in preclinical and clinical settings of acute respiratory distress syndrome (ARDS) and primary graft dysfunction (PGD). In fact, PFR has been shown to indicate early signs of lung injury in both ARDS and PGD settings. In the present study, we explored whether PFR could be used as a marker for BOS.Methods: Lung transplant patients with different BOS grades were included. All patients were in stable condition without ongoing infections and >2 years posttransplantation. PFR (in particles per liter) was measured using a Particles in Exhaled Air (PExA) 2.0 device (PExA, Gothenburg, Sweden), containing an optical particle counter, at the start of the study and then 1 year out, in total two time points (0 and 1 year). Particles in the diameter range of 0.41–4.55 µm were measured.Results: At both the start of the study and 1 year out, patients with BOS grade 0 had significantly higher PFR than patients with BOS grades 2–3. During the study period, patients who progressed in their BOS grade all expressed lower PFR as they progressed in BOS grade, while patients who remained stable in BOS grade did not. The particle distribution between the different BOS grades had a similar pattern; however, it significantly decreased PFR with severity in the BOS grade.Conclusions: EBP expressed as PFR could be used to distinguish severity in BOS grade and could be used to follow the progression of BOS over time. PFR could be used as a new diagnostic tool for BOS and to follow the development of lung function over time.Keywords
This publication has 30 references indexed in Scilit:
- Different particle flow patterns from the airways after recruitment manoeuvres using volume-controlled or pressure-controlled ventilationIntensive Care Medicine Experimental, 2019
- A new way of monitoring mechanical ventilation by measurement of particle flow from the airways using Pexa method in vivo and during ex vivo lung perfusion in DCD lung transplantationIntensive Care Medicine Experimental, 2018
- Bronchoalveolar Lavage: Quantitative Mass Spectrometry-Based Proteomics Analysis in Lung Diseases2017
- Bronchoscopy Safety in Patients With Chronic Obstructive Lung DiseaseJournal of Bronchology & Interventional Pulmonology, 2017
- Low Levels of Exhaled Surfactant Protein A Associated With BOS After Lung TransplantationTransplantation Direct, 2016
- Potential of Mass Spectrometry in Developing Clinical Laboratory Biomarkers of Nonvolatiles in Exhaled BreathClinical Chemistry, 2016
- Exhaled particles as markers of small airway inflammation in subjects with asthmaClinical Physiology and Functional Imaging, 2015
- An International ISHLT/ATS/ERS Clinical Practice Guideline: Summary for Clinicians. Bronchiolitis Obliterans Syndrome Complicating Lung TransplantationAnnals of the American Thoracic Society, 2015
- An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndromeEuropean Respiratory Journal, 2014
- Detection of Nonvolatile Macromolecules in Breath: A Possible Diagnostic Tool?American Review of Respiratory Disease, 1993